Strength
175 ug/3mL
Manufacturer
Viatris Specialty LLCNDC
49502080693
Classification
Brand
Dosage Form
SOLUTION
Route
RESPIRATORY (INHALATION)
Last Updated
1/1/2026
Active Ingredients
REVEFENACINApproval Type
New Drug (NDA)
FDA Application
NDA210598On Market Since
12/3/2018
Pharmacological Classes
Anticholinergic
Cholinergic Antagonists
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
CUVPOSA 1 MG/5 ML SOLUTION
Brand
00259050116•Merz Pharmaceuticals, LLC
$1.0081
per ML
LOMOTIL 2.5-0.025 MG TABLET
Brand
00025006131•Pfizer Inc.
$3.0028
per EA
MOTOFEN 1-0.025 MG TABLET
Brand
54766020010•Sebela Pharmaceuticals Inc.
$6.9129
per EA
ANORO ELLIPTA 62.5-25 MCG INH
Brand
00173086910•GlaxoSmithKline LLC
$7.8122
per EA
ANORO ELLIPTA 62.5-25 MCG INH
Brand
00173086906•GlaxoSmithKline LLC
$8.0331
per EA
INCRUSE ELLIPTA 62.5 MCG INH
Brand
00173087306•GlaxoSmithKline LLC
$10.2684
per EA
SPIRIVA HANDIHALER 18 MCG CAP
Brand
00597007547•Boehringer Ingelheim Pharmaceuticals Inc.
$10.6188
per EA
SPIRIVA HANDIHALER 18 MCG CAP
Brand
00597007541•Boehringer Ingelheim Pharmaceuticals Inc.
$10.6228
per EA
TRELEGY ELLIPTA 100-62.5-25
Brand
00173088714•GlaxoSmithKline LLC
$11.1502
per EA
TRELEGY ELLIPTA 200-62.5-25
Brand
00173089310•GlaxoSmithKline LLC
$11.1626
per EA